14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー Chronic inflammatory demyelinating polyneuropathy Clinical trials / Disease details

臨床試験数 : 175 / 薬物数 : 161 - (DrugBank : 41) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 24

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003592-34-DK (EUCTR)	02/08/2019	14/03/2019	Subcutaneous versus intravenous administration of immunoglobulin in newly diagnosed patients with ch ...	Subcutaneous immunoglobulin in de-novo CIDP(Randomized, parallel study of subcutaneous versus intrav ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 21.1;Level: PT;Classificati ...	Trade Name: Hizentra Product Name: Hizentra INN or Proposed INN: Human Immunoglobulin G Other descripti ...	Aarhus University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 4	Denmark
2	EUCTR2013-001428-20-DK (EUCTR)	06/06/2013	06/06/2013	Study of the effect of subcutaneous administration of immunoglobulin in patients with newly diagnose ...	Randomized, single-blind crossover study of subcutaneous immunoglobulin in newly diagnosed patients ...	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) MedDRA version: 16.0;Level: PT;Clas ...	Trade Name: Hizentra Product Name: Hizentra INN or Proposed INN: Human normal immunoglobulin Other desc ...	Aarhus University Hospital	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Denmark
3	EUCTR2009-017672-24-FI (EUCTR)	30/11/2010	10/09/2010	This research study will investigate whether the investigational medicine IgPro10 is efficient and s ...	A single-arm study to demonstrate the efficacy and safety of Privigenin the treatment of subjects wi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 14.0;Level: PT;Classificati ...	Trade Name: Privigen® INN or Proposed INN: Human normal immunoglobulin G (IgG > 98% purity) Other descr ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	30		Finland
4	NCT01184846 (ClinicalTrials.gov)	November 2010	18/8/2010	Study of Efficacy and Safety of Privigenin Subjects With Chronic Inflammatory Demyelinating Polyneur ...	A Single-arm Study to Demonstrate the Efficacy and Safety of Privigenin the Treatment of Subjects Wi ...	Chronic Inflammatory Demyelinating Polyneuropathy	Biological: 10% liquid formulation of human immunoglobulin	CSL Behring	NULL	Completed	18 Years	N/A	All	31	Phase 3	Belgium;Finland;France;Germany;Poland
5	EUCTR2009-017672-24-BE (EUCTR)	13/09/2010	07/07/2010	A single-arm study to demonstrate the efficacy and safety of Privigenin the treatment of subjects wi ...	A single-arm study to demonstrate the efficacy and safety of Privigenin the treatment of subjects wi ...	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) MedDRA version: 13.1;Level: PT;Classificati ...	Trade Name: Privigen® INN or Proposed INN: Human normal immunoglobulin G (IgG > 98% purity) Other descr ...	CSL Behring GmbH	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 3	Finland;Belgium

First Previous1Next Last